Zevtera

Active Ingredient(s): Ceftobiprole Medocaril Sodium
FDA Approved: * April 3, 2024
Pharm Company: * BASILEA PHARM ALLSCH
Category: Antibiotics
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zevtera 667 mg Intravenous Injection, Powder, for Solution
NDC: 68547-578
Labeler:
La Jolla Pharmaceutical Company
Zevtera 667 mg/10ml Intravenous Injection, Powder, for Solution
NDC: 84312-001
Labeler:
Basilea Pharmaceutica International Ag, Allschwil